Indian Medicines Pharmaceutical Corporation Limited (IMPCL) is a CPSE under the administrative control of Ministry of AYUSH, Govt. of India which is engaged in Manufacturing and Marketing of Ayurvedic and Unani Medicines.
As the purpose of establishment of IMPCL is to fulfill the need of CGHS, CCRAS, CCRUM, ESIC, Central/ State government institution(s) for the continous supply of Ayurvedic & Unani Medicines as per their programme requirements.
Presently, IMPCL has achieved the said objective and able to complete their requirements and also committed to serve better for their future requirements. The three years financial performances are as under:
|
|
|
(Rs. in lacs) |
| Description |
2022-23 |
2023-24 |
2024-25 |
| Paid-up Capital |
5,198.00 |
5,198.00 |
5,198.00 |
| Reserve & Surplus |
7,618.32 |
8,258.27 |
9,350.74 |
| Net Worth |
12,816.32 |
13,456.27 |
14,548.74 |
| Fixed Assets (Net Worth) |
2,134.67 |
2,012.22 |
1,813.79 |
| Turnover |
22,322.79 |
16,150.43 |
17,730.56 |
| Misc. Income |
320.25 |
217.49 |
249.17 |
| Total Income |
22,643.04 |
16,367.92 |
17,979.73 |
| Depriciation |
271.97 |
250.38 |
229.00 |
| Net Profit before tax |
2,948.89 |
1,773.34 |
2,419.19 |
| Net Profit after tax |
2,081.01 |
1,280.76 |
1,765.28 |
| % of Net Profit after tax to Income |
9.19 |
7.82 |
9.82 |
| Earning per share (Rs) |
4.0 |
2.46 |
3.40 |
| Net Profit Ratio (Before tax) |
13.21 |
10.98 |
13.64 |
| Net Profit Ratio (After tax) |
9.32 |
7.93 |
9.96 |
| Net Worth/ per Rupee of Paid up Capital |
2.47 |
2.59 |
2.80 |